Summary
| Direction in PACVS | ↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction |
|---|---|
| Category | Molecular |
| Also described as | Modified 3'UTR / 2P spike region |
| Compared against | HC (healthy controls) |
| Associated symptoms | Persistent vaccine mRNA detection |
| Test type | Clinical or physiological test |
| Source | Camperi et al. 2025 — doi:10.3390/molecules30071629 |
| Condition atlas | PACVS Biomarker Atlas |
Related Molecular markers in PACVS
- Wild-type viral spike peptides ↓
- Vaccine mRNA (hybrid 3'UTR motifs) ↕
- 2P proteotypic peptides (K986P/V987P) ↑
Full list: PACVS Biomarker Atlas.
Frequently asked questions
Is BNT162b2 vaccine mRNA (qPCR) high or low in PACVS?
Mixed. Some studies report higher and others lower BNT162b2 vaccine mRNA (qPCR) in PACVS compared with healthy controls, so no single direction is established. Source: Camperi et al. 2025.
What symptoms is BNT162b2 vaccine mRNA (qPCR) associated with in PACVS?
The cited literature associates this marker with Persistent vaccine mRNA detection. These are population-level associations and do not mean the marker causes the symptoms.
Which test measures BNT162b2 vaccine mRNA (qPCR)?
It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal BNT162b2 vaccine mRNA (qPCR) result diagnostic of PACVS?
No. No single biomarker is diagnostic of PACVS. BNT162b2 vaccine mRNA (qPCR) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.